Abstract
Evidence that inherited susceptibility plays a role in the risk of malignancy comes from three separate sources. These observations are that:
-
1.
In some syndromes which are rare in the general population but which are clearly genetically determined, there is a dramatically increased risk of cancer in gene carriers over and above that of the general population. Often these syndromes predispose to cancers which are rare outside this context and the cancers are diagnosed at atypically young ages.
-
2.
Occasionally, families are found which contain a number of cases of ‘common’ cancers and the number of such cases in these families far exceeds that predicted by population rates. Again, many of these families exhibit cancers at noticeably young ages.
-
3.
On a population level there is an increased risk of cancer to relatives of cancer cases; in many cases the relatives are at increased risk of the same cancer although relatives may also be at increased risk of other cancers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
McKusick, V.A., Francomano, C.A. and Anton-arakis, S.E. (1992) Mendelian Inheritance in Man: Catalogs of Autosomal Dominant, Autosomal Recessive, and X-linked Phenotypes, 10th edn, Johns Hopkins University Press, Baltimore.
Fraser Roberts, J. A. and Pembrey, M.E. (1985) An Introduction to Medical Genetics, 8th edn, Oxford University Press, Oxford.
Northover, J.M.A. and Murday, V.A. (1989) Familial colorectal cancer and familial adenomatous polyposis. Baillière’s Clin. Gastroen-terol., 3(3), 613.
Lockhart-Mummery, P. (1925) Cancer and heredity. Lancet, i, 427–9.
Vogel, F. (1979) Genetics of retinoblastoma. Hum. Genet., 52, 1–54.
Larsson, C. and Nordenskjöld, M. (1990) Multiple endocrine neoplasia. Cancer Surv., 9, 703–23.
Bülow, S. (1987) Familial and polyposis coli. A clinical and epidemiological study. Dan. Med. Bull., 34, 1–15.
Hodgson, S.V. and Maher, E.R. (1993) A Practical Guide to Human Cancer Genetics, Cambridge University Press, Cambridge.
Gardner, E.J. and Stephens, F.E. (1950) Breast cancer in one family group. Am. J. Hum. Genet., 2, 30–40.
Fraumeni, J.F., Grundy, G.W., Creagan, E.T. and Everson, R.B. (1975) Six families prone to ovarian cancer. Cancer, 36(2), 364–9.
Lynch, H.T., Harris, R.E., Guirgis, H.A., Maloney, K.M., Carmody, L.L. and Lynch, J.F. (1978) Familial association of breast/ ovarian cancer. Cancer, 41, 1543–9.
Lynch, H.T. and Watson, P. (1990) Early age at breast cancer onset — a genetic and oncologic perspective. Am. J. Epidemiol, 131(6), 984–6.
Lynch, H.T., Watson, P., Conway, T.A. and Lynch, J.F. (1990) Clinical/genetic features in hereditary breast cancer. Breast Cancer Res. Treat., 15(2), 63–71.
Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A., Goldgar, D.E. and the Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCAl-mutation carriers. Lancet, 343, 692–5.
Lynch, H.T., Rozen, P., Schuelke, G.S. et al. (1984) Hereditary colorectal cancer review: colonic polyposis and nonpolyposis colonic cancer (Lynch Syndrome I and II). Surv. Dig. Dis., 2, 244–60.
Lynch, H.T., Watson, P., Kriegler, M. et al. (1988) Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis. Colon Rectum, 31(5), 372–7.
Menko, F.H. (1993) Genetics of Colorectal Cancer for Clinical Practice, Kluwer, Dordrecht, The Netherlands.
Cannon-Albright, L.A., Bishop, D.T., Godgar, G. and Skolnick, M.H. (1991) Genetic predisposition to cancer, in Important Advances in Oncology, (eds V.T. DeVita, S. Hellman and S.A. Rosenberg) Lippincott, USA pp. 39–55.
Easton, D. and Peto, J. (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surv., 9(3), 395–416.
Claus, E.B., Risch, N.J. and Thompson, W.D. (1990) Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol, 131, 961–72.
Claus, E.B., Risch, N. and Thompson, W.D. (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone study. Am. J. Hum. Genet., 48(2), 232–42.
Clarke, C.A. (1961) Blood groups and disease, in Progress in Medical Genetics, (ed. A.G. Steinberg), Vol. 1, Grune and Stratton, New York, pp. 81–119.
Botstein, D., White, R., Skolnick, M. and Davis, R. (1980) Construction of a genomic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet., 32(3), 314–31.
Huson, S.M., Compston, D.A.S. and Harper, P.S. (1989) A genetic study of von Reckling-hausen neurofibromatosis in South East Wales. II Guidelines for genetic counselling. J. Med. Genet., 26(11), 712–21.
Lewis, R.A., Riccardi, V.M., Gerson, L.P., Whitford, R. and Axelson, K. A. (1984) Von Recklinghausen neurofibromatosis: II. Incidence of optic-nerve gliomata. Ophthalmology, 91, 929–35.
Alm, T. and Licznerski, G. (1973) The intestinal polyposes. Clin. Gastroenterol, 2(3), 577–602.
Bodmer, W.F., Bailey, C.J., Bodmer, J. et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature, 328, 614–16.
Groden, J., Thliveris, A., Samowitz, W. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589–600.
Maher, E.R. (1991) Genetic mechanisms in von Hippel-Lindau disease. Lancet, 337, 1478–9.
Johnson, J.A. (1989) Ataxia telangiectasia and other α-fetoprotein-associated disorders, in Genetic Epidemiology of Cancer, (eds H.T. Lynch and T. Hirayama) CRC Press, Boca Raton, pp. 145–7.
Eng, C., Stratton, M., Ponder, B., et al. (1994) Familial cancer syndromes. Lancet, 343, 709–13.
Saad, M.F., Ordonez, N.G., Rashid, R.K. et al. (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine, 63(6), 319–39.
Mulligan, L.M., Knole, J.B.J., Healey, C.S. et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458–60.
Cannon-Albright, L.A., Goldgar, D.E., Meyer, L.J. et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science, 258, 1148–52.
Cannon-Albright, L.A., McWhorter, W.P., Meyer, L.J. et al. (1993) Penetrance and expressivity of the chromosome 9p melanoma susceptibility gene. Am. J. Hum. Genet., 53(3)Suppl, 171.
Nancarrow, D.J., Mann, G.J., Holland, E.A. et al. (1993) Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet., 53(4), 936–42.
Easton, D.F., Bishop, D.T., Ford, D., Crock-ford, G.P. and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52(4), 678–701.
Peltomäki, P., Aaltonen, L.A., Sistonen, P. et al. (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science, 260, 810–12.
Fishel, R., Lescoe, M.K., Rao, M.R.S. et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027–38.
Leach, F.S., Nicolaides, N.C., Papadopoulos, N. et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75, 1215–25.
Anderson, D.E. (1980) An inherited form of large bowel cancer. Muir’s syndrome. Cancer, 45(suppl. 5), 1103–7.
Lindblom, A., Tannergård, P., Werelius, B. and Nordenskjöld, M. (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet., 5(3), 279–82.
Bronner, C.E., Baker, S.M. Morrison, P.T. et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature, 358, 258–61.
Papadopoulos, N., Nicolaides, N.C., Wei, Y.-F. et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science, 263, 1625–9.
Hall, N.R., Murday, V.A., Chapman, P. et al. (1994) Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur. J. Cancer, 30A(2), 180–2.
Malkin, D., Li, F.P., Strong, L.C. et al. (1990) Germ Line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233–8.
Teich, N.M. (1991) Oncogenes and cancer, in Introduction to the Cellular and Molecular Biology of Cancer, 2nd edn, (eds L.M. Franks and N.M. Teich), Oxford University Press, Oxford, pp. 230–68.
Ponder, B. (1988) Gene losses in human tumours. Nature, 335, 400–2.
Wyllie, A.H., Ashton-Rickardt, P., Dunlop, M.G. et al. (1990) Status of the APC gene in familial and sporadic colorectal tumours as determined by closely flanking markers, in Hereditary Colorectal Cancer, (eds J. Utsunomiya and H.T. Lynch), Springer-Verlag, Tokyo, pp. 453–6.
Vogelstein, B., Fearon, E.R., Hamilton, S.R. et al. (1988) Genetic alterations in colorectal tumour development. N. Engl. J. Med., 319(9), 525–32.
Bodmer, W.F., Bishop, D.T. and Karran, P. (1994) Genetic steps in colorectal cancer. Nature Genet., 6(4), 217–19.
St John, D.J.B., McDermott, F.T., Hopper, J.L., Debney, E.A., Johnson, W.R. and Hughes, E.S.R. (1993) Cancer risk in relatives of patients with common colorectal-cancer. Ann. Intern. Med. 118(10), 785–90.
Anderson, D.E. (1980) Risk in families of patients with colon cancer, in Colorectal Cancer: Prevention, Epidemiology and Screening, (eds S. Winawer, D. Schottenfeld and P. Sherlock) Raven Press, New York, pp. 109–15.
Bishop, D.T. and Thomas, H.J.W. (1990) The genetics of colorectal cancer. Cancer Surv. 9(4), 585–604.
Wolf, C.R. (1990) Metabolic factors in cancer susceptibility. Cancer Surv., 9(3), 437–4.
Zhong, S., Wyllie, A.H., Barnes, D., Wolf, C.R. and Spurr, N.K. (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14(9), 1821–4.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bishop, D.T. (1996). Genetic predisposition to cancer: an introduction. In: Eeles, R.A., Ponder, B.A.J., Easton, D.F., Horwich, A. (eds) Genetic Predisposition to Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4501-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-4501-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-56580-9
Online ISBN: 978-1-4899-4501-3
eBook Packages: Springer Book Archive